|
Market Closed -
London S.E.
19:35:28 24/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.1300 GBX | +4.00% |
|
0.00% | -39.53% |
| Market Cap | 6.26M 7.31M 5.86M 5.36M 10.11M 700M 10.21M 69.32M 26.96M 351M 27.44M 26.84M 1.16B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 11.17M 13.03M 10.45M 9.55M 18.02M 1.25B 18.21M 124M 48.06M 626M 48.92M 47.86M 2.07B | EV / Sales 2026 * |
5.96x | EV / Sales 2027 * | - |
| Free-Float |
90.13% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +4.00% | ||
| Current month | +18.18% | ||
| 1 month | +4.00% | ||
| 3 months | -26.97% | ||
| 6 months | -51.85% | ||
| Current year | -39.53% |
| 1 week | 0.12 |  | 0.14 |
| 1 month | 0.1 | | 0.17 |
| Current year | 0.08 | | 0.34 |
| 1 year | 0.08 | | 0.75 |
| 3 years | 0.08 | | 52 |
| 5 years | 0.08 | | 53.6 |
| 10 years | 0.08 | | 278.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Compton
CEO | Chief Executive Officer | - | 30/06/2026 |
| Chief Tech/Sci/R&D Officer | 64 | 08/06/2007 | |
Paul Stockdale
DFI | Director of Finance/CFO | - | 15/09/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 08/06/2007 | |
Paul Stockdale
BRD | Director/Board Member | - | 15/09/2017 |
David Holbrook
BRD | Director/Board Member | 65 | 05/04/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/11/25 | Free | Founder | 15,000,000 | 0.7663% | ||
| 10/11/25 | Free | Executive/Senior Manager | 15,000,000 | 0.7663% | ||
| 10/11/25 | Free | Chief Operating Officer | 15,000,000 | 0.7663% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.00% | 0.00% | -72.63% | -98.83% | 7.31M | |
| +0.04% | -1.45% | -12.03% | -30.35% | 2.54B | |
| -2.79% | +0.28% | +0.94% | -84.28% | 1.98B | |
| +2.48% | +0.51% | -14.57% | -1.10% | 353M | |
| +1.82% | -5.49% | -48.27% | - | 50.77M | |
| Average | +1.13% | -0.27% | -29.31% | -53.64% | 986.93M | |
| Weighted average by Cap. | -0.87% | +0.34% | -7.46% | -50.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.87M 2.18M 1.75M 1.6M 3.02M 209M 3.05M 20.72M 8.06M 105M 8.2M 8.02M 347M | - |
| Net income | - | - |
| Net Debt | 4.9M 5.72M 4.59M 4.19M 7.91M 548M 8M 54.28M 21.1M 275M 21.48M 21.02M 910M | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/08/26 | GBX 0.1300 | +4.00% | 6,601,658 |
| 21/08/26 | GBX 0.1250 | 0.00% | 1,886,741 |
| 20/08/26 | GBX 0.1250 | 0.00% | 5,968,574 |
| 19/08/26 | GBX 0.1250 | -4.58% | 28,696,332 |
| 18/08/26 | GBX 0.1310 | +0.77% | 20,828,199 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001250GBP
Average target price
0.0100GBP
Spread / Average Target
+700.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OBD Stock
Select your edition
All financial news and data tailored to specific country editions
